SGLT2 inhibitors are associated with a reduced incidence of atrial fibrillation in type 2 diabetes mellitus

Documenti analoghi

• SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany
  di: Theresia Sarabhai, et al.
  Pubblicazione: (2025)
• Incidence and risk factors of new‐onset diabetes mellitus: A five‐year follow‐up study in solid organ transplant recipients in Germany
  di: Theresia Sarabhai, et al.
  Pubblicazione: (2024)
• Sex and Body Mass Index differences in the incidence of vascular and cardiometabolic diseases: A retrospective cohort study including 233 730 patients in Germany
  di: Ximena Orozco‐Ruiz, et al.
  Pubblicazione: (2025)
• Annual prevalence and factors associated with body mass index documentation in German general practices—A retrospective cross‐sectional study
  di: Ximena Orozco‐Ruiz, et al.
  Pubblicazione: (2025)
• Association between new‐onset atrial fibrillation and dementia among individuals with type 2 diabetes
  di: Ying Zhou, et al.
  Pubblicazione: (2024)